S-1 Filing

ALIGNMENT HEALTHCARE, INC. CIK: 1832466

Filing Information

Form Type	S-1
Accession Number	`0001193125-21-331203`
Period End Date	20210930
Filing Date	20211116
Fiscal Year	N/A
Fiscal Period	N/A
XBRL Instance	d29089ds1_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 89 Income Statement 98 Cash Flow Statement 149 Stockholders Equity 53

Balance Sheet 89 line items

Line Item	Tag	Value	Unit	Period
Cash	`Cash`	$86.48M	USD	Point-in-time
Cash	`Cash`	$207.31M	USD	Point-in-time
Cash	`Cash`	$500.49M	USD	Point-in-time
Accounts receivable , net	`AccountsReceivableNetCurrent`	$47.67M	USD	Point-in-time
Accounts receivable , net	`AccountsReceivableNetCurrent`	$40.14M	USD	Point-in-time
Accounts receivable , net	`AccountsReceivableNetCurrent`	$35.63M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$5.24M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$17.23M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$29.24M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$577.39M	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$74.00K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$264.68M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$127.35M	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	-	USD	Point-in-time
Allowance for credit losses	`AllowanceForDoubtfulAccountsReceivableCurrent`	$1.14M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$31.50M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.14M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$27.44M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	100.00M	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$9.89M	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$8.27M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	0.00	shares	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$34.97M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$35.21M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$34.65M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Restricted and other assets	`OtherRestrictedAssetsNoncurrent`	$2.15M	USD	Point-in-time
Restricted and other assets	`OtherRestrictedAssetsNoncurrent`	$3.68M	USD	Point-in-time
Restricted and other assets	`OtherRestrictedAssetsNoncurrent`	$4.54M	USD	Point-in-time
Total assets	`Assets`	$193.44M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$338.50M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total assets	`Assets`	$656.93M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	1.00B	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	164.06M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	187.25M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	164.06M	shares	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$128.78M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	164.06M	shares	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$112.61M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	187.25M	shares	Point-in-time
Medical expenses payable	`MedicalExpensesPayableCurrent`	$102.38M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$15.35M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$15.68M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$16.56M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$12.52M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$29.81M	USD	Point-in-time
Accrued compensation	`AccruedCompensation`	$25.17M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$175.14M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$130.26M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$153.45M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$148.97M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$144.17M	USD	Point-in-time
Long-term debt, net of debt issuance costs	`LongTermDebtNoncurrent`	$137.96M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingAndFinanceLeaseLiabilityNoncurrent`	$7.74M	USD	Point-in-time
Long-term portion of lease liabilities	`OperatingAndFinanceLeaseLiabilityNoncurrent`	$10.27M	USD	Point-in-time
Other Noncurrent Liabilities	`OtherLiabilitiesNoncurrent`	$3.94M	USD	Point-in-time
Total liabilities	`Liabilities`	$307.89M	USD	Point-in-time
Total liabilities	`Liabilities`	$272.15M	USD	Point-in-time
Total liabilities	`Liabilities`	$331.85M	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of September 30, 2021 and December 31, 2020, respectively; no shares issued and outstanding as of September 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $.001 par value; 100,000,000 and 0 shares authorized as of September 30, 2021 and December 31, 2020, respectively; no shares issued and outstanding as of September 30, 2021 and December 31, 2020	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 and 164,063,787 shares authorized as of September 30, 2021 and December 31, 2020, respectively; 187,250,836 and 164,063,787 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$164.00K	USD	Point-in-time
Common stock, $.001 par value; 1,000,000,000 and 164,063,787 shares authorized as of September 30, 2021 and December 31, 2020, respectively; 187,250,836 and 164,063,787 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$188.00K	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$851.89M	USD	Point-in-time
Additional Paid in Capital	`AdditionalPaidInCapital`	$410.02M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-527.02M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-379.57M	USD	Point-in-time
Accumulated equity (deficit)	`RetainedEarningsAccumulatedDeficitAndStockholdersEquity`	$-78.71M	USD	Point-in-time
Accumulated equity (deficit)	`RetainedEarningsAccumulatedDeficitAndStockholdersEquity`	$30.61M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$325.06M	USD	Point-in-time
Total Alignment Healthcare, Inc. stockholders' equity	`StockholdersEquity`	$30.61M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	-	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$15.00K	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$325.07M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.68M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-78.71M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$50.86M	USD	Point-in-time
Total liabilities and stockholders or member 's equity (deficit)	`LiabilitiesAndStockholdersEquity`	$338.50M	USD	Point-in-time
Total liabilities and stockholders or member 's equity (deficit)	`LiabilitiesAndStockholdersEquity`	$193.44M	USD	Point-in-time
Total liabilities and stockholders or member 's equity (deficit)	`LiabilitiesAndStockholdersEquity`	$656.93M	USD	Point-in-time

Income Statement 98 line items

Line Item	Tag	Value	Unit	Period
Earned premiums	`PremiumsEarnedNet`	$713.71M	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$245.49M	USD	1 Quarter
Earned premiums	`PremiumsEarnedNet`	$753.97M	USD	Annual
Earned premiums	`PremiumsEarnedNet`	$955.39M	USD	Annual
Earned premiums	`PremiumsEarnedNet`	$869.01M	USD	3 Qtrs
Earned premiums	`PremiumsEarnedNet`	$293.27M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$191.00K	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$485.00K	USD	3 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$2.99M	USD	Annual
Other	`RevenueNotFromContractWithCustomer`	$3.10M	USD	3 Qtrs
Other	`RevenueNotFromContractWithCustomer`	$2.38M	USD	1 Quarter
Other	`RevenueNotFromContractWithCustomer`	$3.83M	USD	Annual
Total revenues	`Revenues`	$756.96M	USD	Annual
Total revenues	`Revenues`	$247.87M	USD	1 Quarter
Total revenues	`Revenues`	$959.22M	USD	Annual
Total revenues	`Revenues`	$716.81M	USD	3 Qtrs
Total revenues	`Revenues`	$293.47M	USD	1 Quarter
Total revenues	`Revenues`	$869.50M	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$792.99M	USD	Annual
Medical expenses	`MedicalExpenses`	$253.99M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$577.98M	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$779.47M	USD	3 Qtrs
Medical expenses	`MedicalExpenses`	$190.08M	USD	1 Quarter
Medical expenses	`MedicalExpenses`	$661.39M	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$105.28M	USD	3 Qtrs
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$110.13M	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$156.40M	USD	Annual
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$38.79M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$76.85M	USD	1 Quarter
Selling, general, and administrative expenses	`SellingGeneralAndAdministrativeExpense`	$212.91M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$4.08M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.02M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$14.92M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.10M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$11.72M	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$3.93M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$1.00B	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$964.49M	USD	Annual
Total expenses	`OperatingExpenses`	$694.28M	USD	3 Qtrs
Total expenses	`OperatingExpenses`	$334.92M	USD	1 Quarter
Total expenses	`OperatingExpenses`	$786.45M	USD	Annual
Total expenses	`OperatingExpenses`	$232.81M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$22.53M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-5.26M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-134.61M	USD	3 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$-29.48M	USD	Annual
Income (loss) from operations	`OperatingIncomeLoss`	$-41.45M	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$15.06M	USD	1 Quarter
Interest expense	`InterestExpense`	$12.62M	USD	3 Qtrs
Interest expense	`InterestExpense`	$12.99M	USD	3 Qtrs
Interest expense	`InterestExpense`	$4.41M	USD	1 Quarter
Interest expense	`InterestExpense`	$14.90M	USD	Annual
Interest expense	`InterestExpense`	$16.93M	USD	Annual
Interest expense	`InterestExpense`	$4.27M	USD	1 Quarter
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-48.00K	USD	1 Quarter
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$351.00K	USD	Annual
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$770.00K	USD	3 Qtrs
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-145.00K	USD	3 Qtrs
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$-57.00K	USD	1 Quarter
Other (income) expenses	`OtherNonOperatingExpenseIncome`	$732.00K	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.37M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-4.21M	USD	1 Quarter
Total other expenses	`OtherNonoperatingIncomeExpense`	$-13.39M	USD	3 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-17.66M	USD	Annual
Total other expenses	`OtherNonoperatingIncomeExpense`	$-12.85M	USD	3 Qtrs
Total other expenses	`OtherNonoperatingIncomeExpense`	$-15.25M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-22.93M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-44.73M	USD	Annual
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-45.82M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$9.14M	USD	3 Qtrs
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$10.85M	USD	1 Quarter
Income (loss) before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-147.45M	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$9.14M	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-44.73M	USD	Annual
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-45.82M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-147.45M	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-22.93M	USD	Annual
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$10.85M	USD	1 Quarter
Total weighted-average common shares outstandingbasic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	148.75M	shares	3 Qtrs
Total weighted-average common shares outstandingbasic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	620,939.00	shares	Annual
Total weighted-average common shares outstandingbasic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	152.26M	shares	1 Quarter
Total weighted-average common shares outstandingbasic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	177.83M	shares	1 Quarter
Total weighted-average common shares outstandingbasic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	169.79M	shares	3 Qtrs
Total weighted-average common shares outstandingbasic and diluted	`WeightedAverageNumberOfSharesOutstandingNetOfRestrictedSharesOfCommonStockBasicAndDiluted`	566,200.00	shares	Annual
Net income (loss) per sharebasic and diluted	`EarningsPerShareBasicAndDiluted`	$0.06	USD	3 Qtrs
Net income (loss) per sharebasic and diluted	`EarningsPerShareBasicAndDiluted`	$-79.00	USD	Annual
Net income (loss) per sharebasic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.87	USD	3 Qtrs
Net income (loss) per sharebasic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.26	USD	1 Quarter
Net income (loss) per sharebasic and diluted	`EarningsPerShareBasicAndDiluted`	$-36.92	USD	Annual
Net income (loss) per sharebasic and diluted	`EarningsPerShareBasicAndDiluted`	$0.07	USD	1 Quarter
UNAUDITED PRO FORMA WEIGHTED-AVERAGE NUMBER OF MEMBERSHIP UNITS OUTSTANDINGBASIC AND DILUTED	`WeightedAverageBasicAndDilutedSharesOutstandingProForma`	152.13M	shares	Annual
UNAUDITED PRO FORMA NET LOSS PER UNITBASIC AND DILUTED	`BasicAndDilutedEarningsPerShareProForma`	$-0.15	USD	Annual

Cash Flow Statement 149 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-147.45M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-44.73M	USD	Annual
Net income (loss)	`ProfitLoss`	$9.14M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-22.93M	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$74.00K	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$118.00K	USD	Annual
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$54.00K	USD	3 Qtrs
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$19.00K	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$28.00K	USD	1 Quarter
Provision for doubtful accounts	`ProvisionForDoubtfulAccounts`	$1.42M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$11.88M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$16.58M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$11.30M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$15.46M	USD	Annual
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$1.63M	USD	3 Qtrs
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$1.95M	USD	Annual
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$1.68M	USD	3 Qtrs
Amortization-debt issuance costs and investment discount	`AmortizationOfFinancingCosts`	$2.19M	USD	Annual
Payment-in-kind interest	`PaidInKindInterest`	$2.99M	USD	3 Qtrs
Payment-in-kind interest	`PaidInKindInterest`	$3.12M	USD	3 Qtrs
Payment-in-kind interest	`PaidInKindInterest`	$3.41M	USD	Annual
Payment-in-kind interest	`PaidInKindInterest`	$4.01M	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	3 Qtrs
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-1.01M	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-418.00K	USD	Annual
Loss on disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-990.00K	USD	3 Qtrs
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$980.00K	USD	3 Qtrs
Equity-based compensation and common stock payments	`ShareBasedCompensationAndCommonStockPayments`	$81.79M	USD	3 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$1.16M	USD	Annual
Equity-based compensation	`ShareBasedCompensation`	$2.12M	USD	Annual
Non-cash lease expense	`OperatingLeaseCost`	$2.00M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	-	USD	Annual
Non-cash lease expense	`OperatingLeaseCost`	$1.76M	USD	3 Qtrs
Non-cash lease expense	`OperatingLeaseCost`	$2.32M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$972.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$6.73M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$4.63M	USD	Annual
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$5.78M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$11.83M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.68M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$11.99M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$10.25M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-8.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-2.78M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-1.15M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-35.00K	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$6.46M	USD	Annual
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$36.57M	USD	Annual
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$-2.12M	USD	3 Qtrs
Medical expenses payable	`IncreaseDecreaseInMedicalExpensesPayable`	$15.40M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$645.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$1.29M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-3.50M	USD	3 Qtrs
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-443.00K	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$12.65M	USD	Annual
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$-196.00K	USD	Annual
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$4.64M	USD	3 Qtrs
Accrued compensation	`IncreaseDecreaseInAccruedCompensation`	$7.24M	USD	3 Qtrs
Lease liabilities	`OperatingLeaseLiabilityPayments`	-	USD	Annual
Lease liabilities	`OperatingLeaseLiabilityPayments`	$-1.28M	USD	Annual
Lease liabilities	`OperatingLeaseLiabilityPayments`	$2.78M	USD	3 Qtrs
Lease liabilities	`OperatingLeaseLiabilityPayments`	$-2.36M	USD	3 Qtrs
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	$-1.36M	USD	Annual
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	$-3.94M	USD	Annual
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	-	USD	3 Qtrs
Noncurrent liabilities	`IncreaseDecreaseInNoncurrentLiabilities`	$-3.94M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$17.71M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.56M	USD	Annual
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-48.64M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$9.21M	USD	Annual
Asset acquisition, net of cash received	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.41M	USD	3 Qtrs
Asset acquisition, net of cash received	`PaymentsToAcquirePropertyPlantAndEquipment`	-	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$1.32M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$320.00K	USD	Annual
Purchase of investments	`PaymentsToAcquireInvestments`	$2.48M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireInvestments`	$1.57M	USD	Annual
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$825.00K	USD	Annual
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$575.00K	USD	3 Qtrs
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$325.00K	USD	Annual
Sale of investments	`ProceedsFromSaleOfLongtermInvestments`	$1.43M	USD	3 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-15.71M	USD	Annual
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-15.41M	USD	3 Qtrs
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-10.24M	USD	Annual
Acquisition of property and equipment	`ProceedsFromAcquisitionOfPropertyAndEquipment`	$-10.98M	USD	3 Qtrs
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$100.00K	USD	3 Qtrs
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$100.00K	USD	Annual
Proceeds from the sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-10.24M	USD	Annual
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-17.86M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-11.63M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-16.36M	USD	Annual
Purchase of noncontrolling interest	`ProceedsFromMinorityShareholders`	-	USD	3 Qtrs
Purchase of noncontrolling interest	`ProceedsFromMinorityShareholders`	$15.00K	USD	3 Qtrs
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.36M	USD	3 Qtrs
Equity repurchase	`PaymentsForRepurchaseOfEquity`	$1.47M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$135.00M	USD	3 Qtrs
Issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$390.60M	USD	3 Qtrs
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$29.01M	USD	3 Qtrs
Common stock issuance costs	`PaymentsOfStockIssuanceCosts`	$3.37M	USD	3 Qtrs
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	Annual
Issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$55.00M	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	$854.00K	USD	Annual
Debt issuance costs	`PaymentsOfDebtIssuanceCosts`	-	USD	Annual
Return of capital	`ProceedsFromContributionsToParent`	$1.98M	USD	Annual
Return of capital	`ProceedsFromContributionsToParent`	$1.50M	USD	Annual
Capital contribution	`ProceedsFromContributionsFromParent`	$500.00K	USD	Annual
Capital contribution	`ProceedsFromContributionsFromParent`	$135.00M	USD	Annual
Capital contribution issuance costs	`CapitalContributionissuanceCosts`	-	USD	Annual
Capital contribution issuance costs	`CapitalContributionissuanceCosts`	$3.37M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$52.66M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$360.13M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$130.12M	USD	Annual
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$130.27M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$51.63M	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$136.34M	USD	3 Qtrs
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$121.33M	USD	Annual
Net increase in cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$293.62M	USD	3 Qtrs
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$222.83M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.85M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$501.44M	USD	Point-in-time
Cash and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$222.83M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.85M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$501.44M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	$9.53M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$8.19M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$8.00M	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	$10.72M	USD	Annual
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$43.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$366.00K	USD	Annual
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$438.00K	USD	3 Qtrs
Acquisition of property in accounts payable	`AcquisitionOfPropertyInAccountsPayable`	$106.00K	USD	Annual
Cash	`CashAndCashEquivalentsAtCarryingValue`	$207.31M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$222.33M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$500.49M	USD	Point-in-time
Cash	`CashAndCashEquivalentsAtCarryingValue`	$86.48M	USD	Point-in-time
Restricted cash in restricted and other assets	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Restricted cash in restricted and other assets	`RestrictedCashAndCashEquivalents`	-	USD	Point-in-time
Restricted cash in restricted and other assets	`RestrictedCashAndCashEquivalents`	$950.00K	USD	Point-in-time
Restricted cash in restricted and other assets	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$222.83M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$34.85M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$207.81M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$501.44M	USD	Point-in-time
Cash and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$86.48M	USD	Point-in-time

Stockholders Equity 53 line items

Line Item	Tag	Value	Unit	Period
Common stock issuance costs	`StockIssuedDuringPeriodIssuanceCosts`	-	USD	1 Quarter
Common stock issuance costs	`StockIssuedDuringPeriodIssuanceCosts`	-	USD	1 Quarter
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$325.07M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.68M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-78.71M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$50.86M	USD	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	187.25M	shares	Point-in-time
Beginning Balance, Shares	`CommonStockSharesIssued`	164.06M	shares	Point-in-time
Balance	`LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-33.66M	USD	Point-in-time
Balance	`LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-78.71M	USD	Point-in-time
Balance	`LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$9.14M	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-44.73M	USD	Annual
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-45.82M	USD	1 Quarter
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-147.45M	USD	3 Qtrs
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$-22.93M	USD	Annual
Net income (loss) attributable to Alignment Healthcare, Inc.	`NetIncomeLoss`	$10.85M	USD	1 Quarter
Adjustment to issuance cost estimate related to initial public offering	`StockIssuedDuringPeriodIssuanceCosts`	-	USD	1 Quarter
Adjustment to issuance cost estimate related to initial public offering	`StockIssuedDuringPeriodIssuanceCosts`	-	USD	1 Quarter
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$15.00K	USD	3 Qtrs
Noncontrolling interest attributable to subsidiary	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	-	USD	1 Quarter
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$131.63M	USD	3 Qtrs
Issuance of common stock, net of issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$361.59M	USD	3 Qtrs
Issuance of common stock to third-party business partners	`StockIssuedDuringPeriodValueToTheThirdPartyBusinessProviders`	-	USD	1 Quarter
Issuance of common stock to third-party business partners	`StockIssuedDuringPeriodValueToTheThirdPartyBusinessProviders`	$6.48M	USD	3 Qtrs
Issuance of common stock to stock appreication rights holders	`StockIssuedDuringPeriodValueEmployeeBenefitPlan`	$11.51M	USD	3 Qtrs
Forfeitures	`StockIssuedDuringPeriodValueShareBasedCompensationForfeited`	-	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$30.51M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$63.80M	USD	3 Qtrs
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$304.00K	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.12M	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.16M	USD	Annual
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$980.00K	USD	3 Qtrs
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.36M	USD	3 Qtrs
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$338.00K	USD	1 Quarter
Equity repurchase	`StockRepurchasedDuringPeriodValue`	$1.47M	USD	3 Qtrs
Capital contribution	`PartnersCapitalAccountContributions`	$131.63M	USD	Annual
Capital contribution	`PartnersCapitalAccountContributions`	$500.00K	USD	Annual
Return of Capital	`PartnersCapitalAccountReturnOfCapital`	$1.98M	USD	Annual
Return of Capital	`PartnersCapitalAccountReturnOfCapital`	$1.50M	USD	Annual
Balance	`LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-33.66M	USD	Point-in-time
Balance	`LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-78.71M	USD	Point-in-time
Balance	`LimitedLiabilityCompanyLlcMembersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$340.38M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$325.07M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.68M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-78.71M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$30.61M	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$50.86M	USD	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	187.25M	shares	Point-in-time
Ending Balance, Shares	`CommonStockSharesIssued`	164.06M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.